Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ACMI - Accumed Inc. -- Ignore unavailable to you. Want to Upgrade?

To: BRSteve who wrote (1774)	7/27/1998 1:54:00 PM
From: Sigmund	Read Replies (1) \| Respond to of 1894

Notice that ACMI is holding up today in a down market. The earnings report will be brutal, but the sale of the micro div (which I was not in favor of) will at least clear the air. The company will have cash enough to pursue their strategy. The company will have two lines of business: * the Accu______ cytology stuff which isn't very exciting * the unknown Savant. If they can fix the cytology automation products to provide value that is a big upside bonus. If Savant gets accepted that is of course the main game. Who knows, as a purer play, there could be partners or suitors.